Loading...
Loading...
CDC PLACES (2023, crude) estimates 17.6% of adults in Dayton have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Census population 137,644. Ohio Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Dayton clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Dayton storefront.
Tendon and Ligament Support Therapy in Dayton, OH for clinics & physicians. Biologic therapies for tendon… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Dayton is 42.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 17.6% of adults in Dayton have diagnosed diabetes — 5.6 points above the U.S. 12% figure. Ohio includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for tendon ligament support therapy, not a walk-in clinic.
National Tendon and Ligament Support Therapy notes (how the product actually works)J15 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Dayton is 17.6% or not. PLACES is planning data. The LCD is the claim.
If you already buy tendon ligament support therapy elsewhere, use this page as a check: homologous-use language, current CGS Administrators article IDs, and PLACES 17.6% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 17.6% of adults — 5.6 points above the U.S. 12% figure. Obesity is 42.9%; arthritis is 28.4%. That is place-level BRFSS modeling, not a clinic census and not a Dayton trial.
Body copy and schema dateModified follow a pinned content version date, not a daily timestamp. CDC and CMS figures are cited to the public reports named on the page. Recheck MAC LCDs before each utilization change — those move faster than a landing page.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Ohio.
If you operate in Ohio and another MAC state, say it on the first call. J15 will not port 1:1. We would rather split utilization than watch a sister clinic copy Dayton tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Dayton, OH.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Dayton is J15 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Dayton — 5.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Ohio Part B wound biologics follow this contractor (siblings: KY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Dayton. Useful for joint-program math; still needs a diagnosis and privileging.
No Dayton storefront. Joe Bradley is an active practice owner. tendon ligament support therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.